Document Detail


Sympathetic Nervous System Dysfunction in MS, Linking Neurodegeneration to a Reduced Response to Therapy.
MedLine Citation:
PMID:  22272817     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
A lower than normal function of the sympathetic nervous system (SNS) has been identified early in the course of multiple sclerosis (MS) and has been shown to play a role in the pathology of the disease. In addition, the chronic use of many drugs commonly used by MS patients could further down regulate SNS by interfering with norepinephrine (NE) synthesis/release and/or interfering with the function of the adrenergic receptors in both the brain and in the periphery. This drug-induced down regulation of SNS activity, when imposed on a background of SNS dysfunction, could not only promote immune inflammatory and neurodegenerative processes, but also can lead to a reduced clinical response to immunomodulaory therapies. Furthermore, low SNS activity could contribute to a higher prevalence of disorders such as depression, fatigue and osteoporosis, which has been observed in MS patients. An algorithm could be constructed based on the combination of baseline NE plasma levels and SNS response levels to a β-adrenergic agonist stimulus. This algorithm, corrected for age and gender, would have the potential to identify MS patients who have a reduced response to immunomodulatory therapies.
Authors:
Zohi Sternberg
Related Documents :
21557217 - Human dendritic cells efficiently phagocytose adenoviral oncolysate, but require additi...
21245867 - The semisynthetic flavonoid monoher sensitises human soft tissue sarcoma cells to doxor...
21123167 - A role for serglycin proteoglycan in mast cell apoptosis induced by a secretory granule...
21093097 - Ifn-α boosts epitope cross-presentation by dendritic cells via modulation of proteasom...
16522457 - Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signa...
8572937 - Low levels of poliovirus replication in primary human monocytes: possible interactions ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-20
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Assistant Professor of Neurology Jacobs Neurological Institute Buffalo General Hospital 100 High Street Buffalo, NY, 14203. Email: zs2@buffalo.edu.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Assessing advanced cancer pain in older adults with dementia at the end-of-life.
Next Document:  Stepwise Formation of Iridium(III) Complexes with Monocyclometalating and Dicyclometalating Phosphor...